Profile
Patrick Malloy is currently the Senior Vice President-Investor Relations at Abivax SA since 2023.
Prior to this, he worked as the VP-Investor Relations & Corporate Communications at Arena Pharmaceuticals, Inc. and as the SVP-Investor Relations & Strategic Communications at VectivBio Holding AG.
Patrick Malloy active positions
Companies | Position | Start |
---|---|---|
ABIVAX | Investor Relations Contact | 2023-08-22 |
Former positions of Patrick Malloy
Companies | Position | End |
---|---|---|
VECTIVBIO HOLDING AG | Investor Relations Contact | - |
ARENA PHARMACEUTICALS | Public Communications Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ABIVAX | Health Technology |
Private companies | 2 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Patrick Malloy